Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools

ABSTRACT

Introduction: Tumor-associated proteins released by cancer cells and by tumor stroma cells, referred as ‘cancer secretome’, represent a valuable resource for discovery of potential cancer biomarkers. The last decade was marked by a great increase in number of studies focused on various aspects of cancer secretome including, composition and identification of components externalized by malignant cells and by the components of tumor microenvironment.

Areas covered: Here, we provide an overview of achievements in the proteomic analysis of the cancer secretome, elicited through the tumor-associated interstitial fluid recovered from malignant tissues ex vivo or the protein component of conditioned media obtained from cultured cancer cells in vitro. We summarize various bioinformatic tools and approaches and critically appraise their outcomes, focusing on problems and challenges that arise when applied for the analysis of cancer secretomic databases.

Expert commentary: Recent achievements in the omics- analysis of structural and metabolic aspects of altered cancer secretome contribute greatly to the various hallmarks of cancer including the identification of clinically significant biomarkers and potential targets for therapeutic intervention.

KEYWORDS:

• Bioinformatics
• biomarker
• cancer secretome
• conditioned media
• proteomics
• tumor interstitial fluid

Disclosure of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Additional information

Funding

This work was supported by grants from CARD: Centre of excellence DNRF125; Innovation Fund Denmark; the Danish Cancer Society, through the budget of the Research Center and The John and Birthe Meyer Foundation.